Hoffman-Censits says atezolizumab has recently undergone a phase II clinical trial for patients with bladder cancer who failed platinum-based chemotherapy.
Jean Hoffman-Censits, MD
Advertisement
Articles by Jean Hoffman-Censits, MD
Hoffman-Censits says outside of the first-line therapy of cisplatin-based chemotherapy in locally advanced unresectable bladder cancer tumors, there are currently no solutions for disease progression.
Advertisement
Latest Updated Articles
Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder CancerPublished: January 13th 2016 | Updated:
- Dr. Jean Hoffman-Censits on the Future of Atezolizumab in Bladder Cancer
Published: March 5th 2016 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
